V804M RET mutation and familial medullary thyroid carcinoma: Report of a large family with expression of the disease only in the homozygous gene carriers

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

1996 • 1,055 citations

Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE.

1991 • 931 citations

The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2

1996 • 725 citations

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1994 • 646 citations

Modification of enzymatic-ally amplified DNA for the detection of point mutations

1989 • 330 citations

Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1995 • 272 citations

A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.

1995 • 253 citations

A New Hot Spot for Mutations in theretProtooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2A¹

1998 • 234 citations

A New Hot Spot for Mutations in the ret Protooncogene Causing Familial Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2A

1998 • 145 citations

Analysis ofRET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas

1995 • 136 citations

Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.

1994 • 113 citations

Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutation

2000 • 109 citations

A Novel Point Mutation in the Intracellular Domain of theretProtooncogene in a Family with Medullary Thyroid Carcinoma1

1997 • 105 citations

Update on the MEN 2A c804 RET mutation: Is prophylactic thyroidectomy indicated?

2000 • 98 citations

Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of theRET proto-oncogene

1996 • 94 citations

Age-associated C-cell hyperplasia in the human thyroid.

1982 • 73 citations

A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma

1998 • 62 citations

A Novel Point Mutation in the Intracellular Domain of the ret Protooncogene in a Family with Medullary Thyroid Carcinoma

1997 • 57 citations

Endocrine changes associated with the human aging process: III. Effect of age on the number of calcitonin immunoreactive cells in the thyroid gland

1985 • 57 citations

Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma

1994 • 54 citations

Mutation of RET codon 768 is associated with the FMTC phenotype

1997 • 43 citations

Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?

2000 • 35 citations

Is thyreoidectomy necessary in RET mutations carries of the familial medullary thyroid carcinoma syndrome

2000 • 26 citations

Management of Individual Tumor Syndromes: Medullary Thyroid Carcinoma and Hyperparathyroidism

1994 • 25 citations

Novel point mutation in exon 10 of theRET proto-oncogene in a family with medullary thyroid carcinoma

1998 • 22 citations

Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?

1998 • 17 citations

Germline V804M Mutation in the RET Proto-oncogene in Two Apparently Sporadic Cases of MTC Presenting in the Seventh Decade of Life

1999 • 17 citations

RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspects

1996 • 14 citations

False-Positive Results of Basal and Pentagastrin-Stimulated Calcitonin in Non-Gene Carriers of Multiple Endocrine Neoplasia Type 2A

1997 • 13 citations

Cited By (0)

Loading...